Grant opportunities
Breakthrough T1D provides funding and support for the best and brightest minds in type 1 diabetes research in Canada. Since our inception, we have been part of almost major breakthrough in T1D research, and we’re always looking for the next big discovery to transform the lives of people with T1D.
If you are a researcher interested in changing the lives of millions of people with T1D, we encourage you to apply for funding and become part of our team.
Take a deeper dive on our research strategy.
*check back often for new funding opportunities.
Open Funding Calls
Breakthrough T1D-SCN Joint Funding Opportunity
Webinar: August 14, 2024 1:00 pm ET
Funding opportunity launch: September 3, 2024
LOI submission deadline: September 24, 2024
CIHR-Breakthrough T1D Operating Grant : Knowledge Mobilization in Diabetes Prevention and Treatment
Program Launch: January 10th, 2024
Application Deadline: May 1st, 2024
Anticipated Notice of Decision: October 31st, 2024
Funding Start Date: November 1st, 2024
Breakthrough T1D Clinician Investigator Fellowship Program
Application Deadline: February 15th, 2025 (midnight PT)
Notice of Decision: Spring 2025
Anticipated Start Date: July 1, 2025
Breakthrough T1D funding opportunities
Breakthrough T1D funding opportunities are open to Canadian researchers through multiple mechanisms, including Strategic Research Agreements, Innovative Grants, training grants for postdoctoral fellows and early career researchers, and Industry Discovery & Development Partnerships.
For additional information on Breakthrough T1D research, please contact Breakthrough T1D’s research team.
The J. Andrew McKee Fellowship Program in Type 1 Diabetes, supported by SCN & Breakthrough T1D
Funding opportunity launch date: November 12, 2024
Notification of intent to apply: January 30, 2025
Application deadline: February 27, 2025
Notice of decision: anticipated May 2025
Funding start date: August 1 – October 15, 2025
Past funding calls
The Breakthrough T1D Canada-Mitacs Postdoctoral Fellowship Program in Type 1 Diabetes
Funding opportunity launch: November 22, 2022
Letter of Intent application deadline: March 24, 2023
Stage 2 application deadline: June 9, 2023
Notice of decision: anticipated August/September 2023
Funding start date: Fall 2023
CIHR-Breakthrough Type 1 Diabetes Screening Research Consortium
Program Launch: November 9th, 2022
Registration: February 15th, 2023
Application Deadline: March 14th, 2023
Notice of Decision: June 30th, 2023
CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Award (III-Breakthrough Type 1 Diabetes Pool)
Application Deadline: May 3, 2023
Notice of Decision: September 2023
Funding Start Date: July 1, 2023
CIRTN-R2FIC Training Program: CIRTN-BREAKTHROUGH-CREATE
Registration: September 4th 2022
Application Deadline: September 18th 2022
Notice of Decision: November 2022
CIHR-BREAKTHROUGH T1D Operating Grants in Diabetes, Psychosocial Health, Prevention, and Self-Management
Program Launch: June 3, 2022
Application deadline: November 1, 2022
Notice of Decision: March 2023
CIHR-BREAKTHROUGH T1D Team Grants: Precision Medicine in Type 1 Diabetes
Program Launch: May 25, 2022
Registration: July 21, 2022
Application Deadline: August 23, 2022
Notice of Decision: January 2023
Breakthrough T1D Canada Mental Health and T1D Community Grants
Program Launch: May 31, 2023
Registration: August 11th, 2023 (5pm ET)
Application Deadline: September 11th, 2023 (5pm ET)
Notice of Decision: October 31, 2023
Earliest Anticipated Start Date: November 15, 2023
Breakthrough T1D – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants
Partnerships
Our research partnerships enable collaboration to achieve shared goals, increase our collective impact, and accelerate our global research strategy. We partner with government agencies, academic institutions, research networks, other non-profit organizations, and industry. Our flexible approach allows us to engage in small to large scale research partnerships through a variety of funding models and mechanisms.
Ongoing and past partnerships:
